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resBACKGROUND Given the shortage of cardiac rehabilitation (CR) programs in India and poor uptake worldwide, there is
an urgent need to find alternative models of CR that are inexpensive and may offer choice to subgroups with poor uptake
(e.g., women and elderly).
OBJECTIVES This study sought to evaluate the effects of yoga-based CR (Yoga-CaRe) on major cardiovascular events
and self-rated health in a multicenter randomized controlled trial.
METHODS The trial was conducted in 24 medical centers across India. This study recruited 3,959 patients with
acute myocardial infarction with a median and minimum follow-up of 22 and 6 months. Patients were individually
randomized to receive either a Yoga-CaRe program (n ¼ 1,970) or enhanced standard care involving educational
advice (n ¼ 1,989). The co-primary outcomes were: 1) first occurrence of major adverse cardiovascular events (MACE)
(composite of all-cause mortality, myocardial infarction, stroke, or emergency cardiovascular hospitalization); and 2)
self-rated health on the European Quality of Life–5 Dimensions–5 Level visual analogue scale at 12 weeks.
RESULTS MACE occurred in 131 (6.7%) patients in the Yoga-CaRe group and 146 (7.4%) patients in the enhanced
standard care group (hazard ratio with Yoga-CaRe: 0.90; 95% confidence interval [CI]: 0.71 to 1.15; p ¼ 0.41). Self-
rated health was 77 in Yoga-CaRe and 75.7 in the enhanced standard care group (baseline-adjusted mean difference
in favor of Yoga-CaRe: 1.5; 95% CI: 0.5 to 2.5; p ¼ 0.002). The Yoga-CaRe group had greater return to pre-infarct
activities, but there was no difference in tobacco cessation or medication adherence between the treatment groups
(secondary outcomes).
CONCLUSIONS Yoga-CaRe improved self-rated health and return to pre-infarct activities after acute myocardial
infarction, but the trial lacked statistical power to show a difference in MACE. Yoga-CaRe may be an option when con-
ventional CR is unavailable or unacceptable to individuals. (A study on effectiveness of YOGA based cardiac rehabilitation
programme in India and United Kingdom; CTRI/2012/02/002408). (J Am Coll Cardiol 2020;75:1551–61) © 2020 The
Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article
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1552C ardiac rehabilitation is an estab-lished standard of care after acutemyocardial infarction with Class I
recommendation for use by the European So-
ciety of Cardiology, American Heart Associa-
tion, and American College of Cardiology
guidelines (1,2). It is a complex interventioninvolving multidisciplinary teams to deliver exercise
training, stress management, psychosocial support,
and secondary prevention (1,2). Cardiac rehabilitation
programs have been shown to improve functioning,
quality of life, and cardiovascular morbidity (3); yet,
participation in cardiac rehabilitation programs re-
mains highly variable worldwide (4,5). The infra-
structure and multidisciplinary teams needed to
deliver such programs are expensive and lacking in
low- and middle-income countries, such as India
(6,7). In many high-income countries, such as the
United States and United Kingdom, participation in
cardiac rehabilitation programs is low among some
subgroups (e.g., elderly, women, low-income) (4,5).
Potentially, low-cost models of cardiac rehabilitation
based on traditional mind-body practices (e.g., yoga,
tai chi), could improve availability of cardiac rehabil-
itation in low- to middle-income countries and also
increase options of exercise training in high-income
countries (8–10). Despite the widespread interest
and ad hoc addition of such practices to conventional
cardiac rehabilitation programs, the effectiveness and
safety of cardiac rehabilitation programs based on
traditional mind-body practices has not been robustly
evaluated.SEE PAGE 1562Yoga is a traditional Indian mind-body practice
that has gained worldwide popularity. It combines
gentle physical exercises (physical functioning) with
breathing and meditation (psychological func-
tioning), and promotes healthy lifestyles (secondary
prevention), thereby inherently addressing the key
objectives of cardiac rehabilitation (11). A few
small-scale trials have evaluated the benefits of
yoga-based cardiac rehabilitation programs (i.e.,
multicomponent interventions, including yoga as
one of the components) in patients with coronary
artery disease and found improvements in func-
tioning, quality of life, cardiovascular risk factors,CaRe trial investigators are listed in the Supplemental Appendix.
l Research, India (ICMR-58/1/9/MRC-ICMR/2009/NCD-II) and Me
. Dr. Chathurvedi has served as a member of the Data Safety an
ve reported that they have no relationships relevant to the con
received November 18, 2019; revised manuscript received Januaand risk of recurrent cardiac events (12–14). We
systematically developed a cardiac rehabilitation
program based on yoga (Yoga-CaRe) and evaluated
its clinical effectiveness and safety in a large ran-
domized trial in India.METHODS
TRIAL DESIGN AND OVERSIGHT. The study protocol
is published (15). The trial was conducted using a
PROBE (Prospective Randomized Open, Blinded-
Endpoint) design. The protocol was approved by the
institutional review boards of the Centre for Chronic
Disease Control, New Delhi, India; London School of
Hygiene & Tropical Medicine, United Kingdom; and
the participating centers. Written informed consent
was obtained from all the participants. The trial was
sponsored by the Indian Council of Medical Research
and the Medical Research Council, United Kingdom,
who had no role in the conduct or reporting of
the trial.
All trial functions, including randomization, data
collection and management, site monitoring, end-
point adjudication, and statistical support, were per-
formed at the Centre for Chronic Disease Control. An
independent data and safety monitoring committee
checked the safety and efficacy data.
TRIAL POPULATION. The trial was conducted in 24
centers across India. Patients aged 18 to 80 years,
with acute myocardial infarction within the past
14 days were eligible if they were willing and able to
complete the hospital-based cardiac rehabilitation
program. Acute myocardial infarction was confirmed
by the World Health Organization’s definition (pres-
ence of symptoms of ischemia and changes in elec-
trocardiogram) or the Third Universal Definition of
Myocardial Infarction (elevation of a cardiac
biomarker along with the presence of either symp-
toms of myocardial infarction or changes in electro-
cardiogram) (16). Patients were excluded if they
practiced yoga regularly (i.e., >3 h per week) or
were participating in other clinical trials, as were
those with diseases that limited their life span to <1
year or were considered unlikely to complete the
study by the local investigator. Patients provided
written informed consent before being randomlyThis research was supported by the Indian Council
dical Research Council, United Kingdom (MRC-MR/
d Monitoring Committee for AstraZeneca. All other
tents of this paper to disclose.
ry 24, 2020, accepted January 27, 2020.
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enhanced standard care. Block randomization, strat-
ified by centers, age (<60 or $60 years), and sex, was
carried out by a central computer program using an
interactive Web response system.
INTERVENTIONS. The details and development pro-
cess of the Yoga-CaRe program is published (17).
Briefly, the Yoga-CaRe program was developed
through a structured process, involving literature
(scientific and yoga) reviews and consultations with
experts (e.g., yoga, cardiac rehabilitation) to identify
the most suitable (safe and effective) yoga exercises
for each component of a conventional cardiac reha-
bilitation program. The draft program was exten-
sively reviewed with yoga and cardiac rehabilitation
experts, piloted, and iteratively refined before it
was finalized.
The Yoga-CaRe program involved 13 direct contact
sessions spread over 12 weeks, with the first session
delivered within 2 weeks of the index cardiac event.
The first 2 sessions were delivered individually and
the remainder in groups at the hospital. Group ses-
sions typically lasted for approximately 75 min and
involved a set of gentle yoga exercises, including
breath control, meditation and relaxation exercises,
followed by a discussion on lifestyle and psychosocial
concerns (Supplemental Tables 1 to 3). The program
allowed for variable combinations and personaliza-
tion of exercises to accommodate varying levels of
fitness of the patients. The sessions were led by yoga
teachers who were trained in the delivery of the Yoga-
CaRe program. The intervention was standardized
with the help of a training video and manual and
annual retraining sessions. Intervention fidelity was
ensured through appropriate feedback following
regular on-site visits and video recording of a random
subset of Yoga-CaRe sessions. The patients were
given an instruction booklet and video in the local
language and encouraged to practice the recom-
mended yoga exercises at home.
Patients in the enhanced standard care arm
received 3 sessions of educational advice with the
help of a leaflet, spread over the same time period as
the Yoga-CaRe sessions. The educational advice was
provided by a different member of the study team
(i.e., not the yoga teacher) to avoid “contamination”
of the treatment arms. Both groups of patients
received the same medical care available to patients
at the hospital. As is typical of India, most centers
(n ¼ 19) did not offer any form of cardiac
rehabilitation.
TRIAL OUTCOMES. The trial had 2 primary outcomes:
occurrence of a major adverse cardiovascular eventduring follow-up and self-rated health at 12 weeks. A
major adverse cardiovascular event was a composite
of death from any cause, nonfatal myocardial infarc-
tion, nonfatal stroke, or emergency cardiovascular
hospitalization. Events were adjudicated by an inde-
pendent committee unaware of trial-group assign-
ments, using standard definitions specified in the
protocol. Self-rated health was assessed by the visual
analogue scale of the European Quality of Life (EQ-
5D-5L) questionnaire, which was completed at base-
line and at 12 weeks (18). We pre-specified visual
analogue scale as the primary outcome because the
descriptive component of EQ-5D-5L lacks conversion
into utilities for India.
The pre-specified secondary endpoints were return
to pre-infarct activities, tobacco cessation, and
medication adherence at 12 weeks. Return to pre-
infarct activities was assessed by the Reintegration
to Normal Living Index questionnaire (score range
from 0 to 110, higher score indicates greater integra-
tion) (19). Adherence to prescribed medication was
assessed by questions derived from a standard in-
strument (20). Tobacco cessation was assessed by
self-reports of tobacco use at baseline and at 12 weeks
by a standard questionnaire. Safety data were
collected on serious adverse events, namely noncar-
diac hospitalizations during the trial and any adverse
event during the Yoga-CaRe sessions.
Additional endpoints analyzed were individual
components of the adverse major cardiac events, and
the descriptive component of the EQ-5D-5L (mobility,
self-care, usual activities, pain/discomfort and anxi-
ety/depression).
Trial outcome data were collected every 3 months
during routine clinical visits. Those missing their clinic
appointments were followed up by a telephone call.
Participants were followed until the end of the trial, with
a pre-specified minimum follow-up period of 6 months
(Supplemental Table 4).
STATISTICAL ANALYSIS. We needed to enroll 3,102
patients to give the trial 80% power (at 0.05 signifi-
cance level) to detect a 20% reduction in event rates
between the treatment groups, assuming an overall
adverse cardiovascular event rate of 20% (anticipated
from the national registry data), allowing for 10% loss
to follow-up (21). Under similar assumptions, 808
patients were needed to detect a 5% difference in
self-rated health on the visual analogue scale of the
EQ-5D-5L. A lower than anticipated number of events
(all-cause mortality, myocardial infarction, or stroke)
mid-trial (December 2016) prompted the inclusion of
emergency cardiovascular hospitalization to the
major adverse cardiovascular event outcome. As
Prabhakaran et al. J A C C V O L . 7 5 , N O . 1 3 , 2 0 2 0
Yoga-CaRe in AMI Patients A P R I L 7 , 2 0 2 0 : 1 5 5 1 – 6 1
1554further increase in sample size was not possible,
the data and safety monitoring committee recom-
mended cessation of enrollment at 4,000 patients
and continued follow-up after reporting the pre-
liminary results, which we present here.
Primary analyses were performed on all partici-
pants according to the intention-to-treat principle.
Cardiovascular event rates were estimated by the
Kaplan-Meier method. Follow-up of the patients was
censored on September 30, 2018, or at the last known
event-free time point, whichever came first. The
hazard ratios for first occurrence of a major adverse
cardiovascular event were determined using a Cox
proportional hazards model, and the Kaplan-Meier
curves were compared using a log-rank test. Anal-
ysis of covariance was used to estimate the mean
difference in the EQ-5D-5L visual analogue scale at
12 weeks, adjusting for baseline values. The second-
ary outcomes were analyzed using linear or logistic
regression models. The descriptive component of the
EQ-5D-5L questionnaire was analyzed without con-
version into utilities by summing the health states
(1 to 5, lower is better) across 5 dimensions and esti-
mating the baseline-adjusted difference in means of
the treatment groups. We estimated the hazard ratios
for individual components of major adverse cardio-
vascular events. We also examined the clinical out-
comes and adherence to Yoga-CaRe intervention
stratified by key subgroups of patients (age, sex, and
with comorbidities). The changes in EQ-5D-5L indi-
vidual dimensions at 3 months were analyzed using
2 approaches. First, following a simpler methodology,
the proportion of patients with some problems
and the changes at 3 months were compared.
Second, we categorized the changes in the individual
dimensions as no change, improved, or worsened
and carried out multinomial logistic regression model
to estimate the treatment difference.
To evaluate the clinical implications of the
magnitude of the change in self-rated health, we
categorized EQ-5D-5L visual analogue scale at
12 weeks following a previously reported model (#60
as poor self-rated health and >60 as good self-rated
health) and commonly accepted model for minimum
clinically important difference (#10-point change as
no change, more than 10-point increase at 12 weeks as
improved, and decrease of more than 10 points as
worsened) (22,23). In the first model, the treatment
difference was estimated using logistic regression
adjusting for baseline values, and in the second
model, a multiple logistic regression model was used.
Similarly, we categorized return to pre-infarct ac-
tivities following a previously reported model after
normalizing the scores to 100 (100 as completereintegration, 60 to 99 as mild to moderate issues,
and <60 as poor reintegration) and the treatment
difference was estimated using multiple logistic
regression (24).
We examined clinical outcomes and adherence to
Yoga-CaRe intervention stratified by key subgroups
of patients (e.g., age, sex, physical activity, and
comorbidities). Also, we examined effect modifica-
tion by study center. We explored the effects of
adherence to intervention by comparing hazards of
incidence major adverse cardiovascular events for
those who were above or below the median for
attendance at direct contact sessions or self-practice
at home (using the same statistical methods as pri-
mary outcome). We confirmed these results by split-
ting the follow-up time into weekly and 3-monthly
intervals, and treating attendance at direct contact
sessions or regular practice at home as time-varying
exposures, respectively.
RESULTS
PATIENTS. Of the 6,737 patients screened for eligi-
bility between August 2014 and March 2018, 3,959
were eligible and randomly assigned to receive Yoga-
CaRe (n ¼ 1,970) or enhanced standard care
(n ¼ 1,989) (see Supplemental Figure 1 for CONSORT
diagram). The mean age of randomized patients was
53.4  10.9 years, of which 14% were women. At the
time of admission, 22% of the patients had a prior
history of coronary heart disease. Angiography was
performed in 80% of the patients and 61% underwent
a revascularization procedure during the index
admission. More than 90% of patients were
receiving #2 standard cardiovascular medications at
hospital discharge. The baseline characteristics of the
2 treatment groups are shown in Table 1.
CLINICAL OUTCOMES. After excluding 38 patients
(17 in Yoga-CaRe group and 21 in enhanced standard
care group) who could not be contacted at all after
randomization, data on 3,921 (99%) patients were
available for analyses. Those who were lost to follow-
up subsequently (n ¼ 48) or withdrew consent for
further participation (n ¼ 24) were included in the
intent-to-treat analyses until the last follow-up.
During a median follow-up of 21.6 months, the first
occurrence of a major adverse cardiovascular event
(composite of all-cause mortality, nonfatal myocar-
dial infarction, nonfatal stroke, or emergency car-
diovascular hospitalization) was recorded for 131
patients in the Yoga-CaRe group and 146 patients in
the enhanced standard care group (6.7% vs. 7.4%;
hazard ratio with Yoga-CaRe: 0.90; 95% confidence
interval [CI]: 0.71 to 1.15; p ¼ 0.41) (Table 2, Figure 1,
TABLE 1 Baseline Characteristics of the Trial Participants
Yoga-CaRe
(n ¼ 1,970)
Enhanced Standard Care
(n ¼ 1,989)
Age, yrs 53.4  11.0 53.4  10.8
Female 271 (13.8) 280 (14.1)
Formal education >10 yrs 1,154/1,966 (58.7) 1,213/1,986 (61.1)
Medical history at admission
Coronary heart disease* 438/1,967 (22.3) 421/1,988 (21.2)
Diabetes mellitus 551/1,962 (28.1) 578/1,988 (29.1)
Hypertension 591/1,964 (30.1) 571/1,987 (28.7)
Congestive heart failure 3/1,969 (0.2) 4/1,988 (0.2)
Chronic kidney disease 7/1,960 (0.4) 6/1,880 (0.3)
Stroke 0/1,969 (0) 2/1,988 (0.1)
Current tobacco use 610/1,967 (31.0) 592/1,986 (29.8)
Current alcohol use 385/1,968 (19.6) 400/1,985 (20.2)
Physical inactivity 1,059/1,966 (53.9) 1078/1,984 (54.3)
Clinical presentation of myocardial infarction
Multivessel disease on angiography 647/1,485 (43.6) 672/1,514 (44.4)
Anterior/anterolateral infarction 961/1,684 (57.1) 989/1,710 (57.8)
ST-segment elevation 1,478/1,970 (75.0) 1,511/1,988 (76.0)
Management at discharge
Received percutaneous coronary intervention 1,128/1,967 (57.4) 1,156/1,988 (58.2)
Use of antiplatelet agent 1,940/1,969 (98.5) 1,960/1,987 (98.6)
Use of statin 1,836/1,969 (93.3) 1,851/1,987 (93.2)
Use of beta-blocker 1,233/1,969 (62.6) 1,244/1,987 (62.6)
Use of ACE inhibitor or ARB 1,013/1,969 (51.4) 982/1,987 (49.4)
Self-rated health† 66.3  17.3 66.7  17.0
Values are mean  SD, n (%), or n/N (%). *Diagnosis of angina or myocardial infarction or revascularization
procedure. †Visual analogue scale of European Quality of Life (EQ-5D-5L) (18).
ACE ¼ angiotensin-converting enzyme; ARB ¼ angiotensin-receptor blocker; Yoga-CaRe ¼ yoga-based cardiac
rehabilitation.
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analogue scale of EQ-5D-5L) at 12 weeks was 77 points
in the Yoga-CaRe group and 75.7 points in the
enhanced standard care group (baseline-adjusted
difference in mean in favor of Yoga-CaRe: 1.50;
95% CI: 0.53 to 2.48; p ¼ 0.002) (Table 2,
Central Illustration).
The return to pre-infarct activities score (Reinte-
gration to Normal Living Index) at 12 weeks was 88.3
in the Yoga-CaRe group and 87.0 in the enhanced
standard care group (difference in mean in favor of
Yoga-CaRe group: 1.30; 95% CI: 0.06 to 2.54;
p ¼ 0.039). There was no difference in tobacco
cessation or medication adherence at 12 weeks be-
tween the treatment groups (Table 2). There was no
difference in serious adverse events between the
treatment groups and no adverse events were re-
ported during the Yoga-CaRe sessions (Table 2).
In nonprotocol defined analysis of EQ-5D-5L data,
the Yoga-CaRe program reduced the odds of having
poor self-rated health at 12 weeks more than the
enhanced standard care (odds ratio: 0.73; p < 0.001).
In the second model, improvements by 10 points in
self-rated health was higher in the Yoga-CaRe group
(relative risk ratio: 1.26; 95% CI: 1.10 to 1.46;
p < 0.001). The Yoga-CaRe group had lower risk of
poor reintegration at 12 weeks (relative risk ratio:
0.72; 95% CI: 0.56 to 0.92; p ¼ 0.001).
There was no treatment difference in the incidence
of individual components of major adverse cardio-
vascular events, although the Yoga-CaRe group had
fewer cardiovascular hospitalizations. In exploratory
subgroup analyses, greater reductions in hazards of
major adverse cardiovascular events were noted in
patients with pre-existing coronary heart disease and
those without diabetes (Figure 2). We found no evi-
dence of interaction by study center (p ¼ 0.25). Of a
total of 13 direct contact sessions, patients in the
Yoga-CaRe group attended a median of 10 (inter-
quartile range: 6 to 13) sessions; there was no differ-
ence in attendance at Yoga-CaRe sessions by sex or
age of the participants.
The percentage of people reporting some problems
in all the individual dimensions at 12 weeks decreased
from baseline in both the groups with higher re-
ductions in the Yoga-CaRe group. Also, the odds of
worsening in the individual domains were lower in
the Yoga-CaRe group. However, these differences did
not reach statistical significance (Supplemental
Tables 5 to 7).
EFFECT OF ADHERENCE TO INTERVENTION (NON-
PROTOCOL SPECIFIED EXPLORATORY ANALYSES).
Those who were above the median for attendance atdirect contact sessions (10 of 13) or self-practice at
home (more than 30 min per day) had a lower inci-
dence of major adverse cardiovascular events as
compared with the enhanced standard care group
(Supplemental Figures 2 and 3). In analyses treating
attendance at direct contact sessions or self-practice
at home as time-varying exposures, the hazard ra-
tios for those achieving the median number of direct
contact sessions or time practicing at home were 0.70
(95% CI: 0.53 to 0.93) and 0.64 (95% CI: 0.49 to
0.84), respectively.
DISCUSSION
In this randomized controlled trial conducted, a yoga-
based cardiac rehabilitation program was found to be
safe and effective in improving quality of life and
return to pre-infarct activities after acute myocardial
infarction. Incidence of major adverse cardiovascular
events was lower in patients enrolled in the
Yoga-CaRe program, but the study lacked statistical
power to show a difference in major adverse cardio-
vascular events.
TABLE 2 Study Outcomes
Yoga-CaRe
(n ¼ 1,953)
Enhanced
Standard Care
(n ¼ 1,968) Effect Variable
Unadjusted Effect
(95% CI) p Value
Primary outcomes
MACE (composite of death, nonfatal myocardial
infarction, nonfatal stroke, or emergency
cardiovascular hospitalization)*
131 (6.7) 146 (7.4) Hazard ratio 0.90 (0.71 to 1.15) 0.41
Self-rated health at 12 weeks† 77.0  16.8 75.7  17.8 Difference in means 1.50 (0.53 to 2.48) 0.002
Secondary outcomes
Return to pre-infarct
activities at 12 weeks‡
88.3  18.9 87.0  20.1 Difference in means 1.30 (0.06 to 2.54) 0.039
High medication adherence at 12 weeks§ 1,199 (64.6) 1,210 (64.3) Odds ratio 1.01 (0.88 to 1.16) 0.88
Tobacco cessation at 12 weeksk 449 (76.2) 445 (77.5) Odds ratio 0.93 (0.71 to 1.22) 0.60
Other outcomes
Death from any cause* 77 (3.9) 77 (3.9) Hazard ratio 1.01 (0.74 to 1.39) 0.95
Nonfatal myocardial infarction* 13 (0.7) 15 (0.8) Hazard ratio 0.88 (0.42 to 1.84) 0.73
Nonfatal stroke* 4 (0.2) 3 (0.2) Hazard ratio 1.34 (0.30 to 6.00) 0.70
Emergency cardiovascular hospitalization* 48 (2.5) 59 (3.0) Hazard ratio 0.82 (0.56 to 1.20) 0.31
Health state at 12 weeks¶ 6.3  2.9 6.5  3.1 Difference in means 0.10 (0.10 to 0.07) 0.23
Safety data
Serious adverse events (noncardiac hospitalizations) 24 (1.2) 26 (1.3) Odds ratio 0.93 (0.53 to 1.63) 0.80
Values are n (%) or mean  SD. *Event rates were based on Kaplan-Meier estimates in time-to-event analysis over the study follow-up period (median 21.6 months). Hazard ratio for first
major adverse cardiovascular event was determined using a Cox proportional hazards model and the p values were calculated by using a log-rank test. †Self-rated health measured by visual
analogue scale of the European Quality of Life questionnaire (EQ-5D-5L) (values from 0–100, higher is better) (18). Analysis of covariance was used to estimate the difference in mean quality
of life of treatment groups at 12 weeks, adjusting for baseline values (n ¼ 1,770 for Yoga-CaRe group, n ¼ 1,786 for enhanced standard care group). ‡Return to pre-infarct activities was
measured by Reintegration to Normal Life Index questionnaire (values from 0–110, higher is better) (19). Difference in means was estimated using linear regression (n ¼ 1,886 for Yoga-CaRe,
n ¼ 1,923 for enhanced standard care group). §Medication adherence was derived by summing the individual items from 8-item questionnaire (values from 0 to 8) and categorized into 2
groups: high adherence (score ¼ 0) and low adherence (score $1) (20). Odds ratio was estimated using logistic regression (n ¼ 1,857 for Yoga-CaRe, n ¼ 1,881 for enhanced standard care
group). kTobacco cessation was defined as cessation of tobacco use (any form) at 12 weeks among those using tobacco at baseline (n ¼ 589 for Yoga-CaRe, n ¼ 574 for enhanced standard care
group). Odds ratio was estimated using logistic regression. ¶Health state was derived by summing the individual health states from descriptive components (mobility, self-care, usual activities,
pain, anxiety/depression) of the European Quality of Life (EQ-5D-5L) questionnaire (values from 5 to 25). Analysis of covariance was used to estimate the difference in mean health state of
treatment groups at 12 weeks, adjusting for baseline values (n ¼ 1,769 for Yoga-CaRe, n ¼ 1,791 for enhanced standard care group).
CI ¼ confidence interval; MACE ¼ major adverse cardiovascular event; Yoga-CaRe ¼ yoga-based cardiac rehabilitation.
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1556COMPARISON WITH PREVIOUS RESEARCH. There
have been few small-scale trials of yoga-based cardiac
rehabilitation and these have also reported improve-
ments in functioning, quality of life, and recurrent
cardiac events. The Lifestyle Heart Trial (n ¼ 48),
conducted in the late 1980s, reported improvements
in cardiovascular risk factors and reduction in total
number of cardiovascular events and need for revas-
cularization over a 5-year follow-up period after a
lifestyle modification program that included yoga
(12). The PrimeTime trial (n ¼ 28) found improve-
ments in psychosocial measures of self-efficacy,
perceived social support, and ability to cope with
stress following a lifestyle intervention including
yoga (14). In another trial from India (n ¼ 42), a car-
diac rehabilitation program that included yoga was
associated with greater reductions in cardiovascular
risk factors, need for revascularization procedures
and size of atherosclerotic lesions on coronary angi-
ography at 1 year, when compared with controls (13).
Our findings are also broadly consistent with trials
of conventional exercise-based cardiac rehabilitation
programs (25,26). The most recent systematic reviewof exercise-based cardiac rehabilitation identified 63
trials (n ¼ 14,486) (3). In trials with medium-term
follow-up, exercise-based cardiac rehabilitation
reduced cardiovascular mortality (risk ratio: 0.74;
95% CI: 0.64 to 0.86) and hospital admissions (risk
ratio: 0.82; 95% CI: 0.70 to 0.96), but not total mor-
tality or myocardial infarction, when compared with
no-exercise controls. Improvements in self-rated
health were also found in most trials that collected
these data (total 20 trials, combined n ¼ 5,060),
although a wide range of measures were used and the
2 that used the European Quality of Life did not show
a difference. Individual trials, including the 2 largest
trials that together contributed 30% of the data to the
systematic review, also could not find conclusive
evidence of benefit. The World Health Organization
study (N ¼ 3,184 from Europe) reported risk ratios of
0.91 (95% CI: 0.75 to 1.10) for total mortality and 1.10
(95% CI: 0.85 to 1.41) for myocardial infarction (27),
whereas RAMIT (Rehabilitation after myocardial
infarction trial) (N ¼ 1,813 from the United Kingdom)
reported risk ratios of 1.02 (95% CI: 0.87 to 1.18) for
total mortality and 0.94 (95% CI: 0.63 to 1.39) for
FIGURE 1 Yoga-CaRe Versus Enhanced Standard Care on Major Cardiovascular Events
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Cumulative incidence of major adverse cardiovascular events (composite of death, nonfatal myocardial infarction, nonfatal stroke, or
emergency cardiovascular hospitalization) in the study groups. Hazard ratio for first major adverse cardiovascular event was determined using
a Cox proportional hazards model and the p value used a log-rank test. Yoga-CaRe ¼ yoga-based cardiac rehabilitation.
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health measured by the Short Form 36 (25). Reviews
of observational (service use) data from the United
States confirm the findings from the trial data, with
continued benefits of cardiac rehabilitation despite
improvements in cardiac care (5,28).
POTENTIAL MECHANISMS. The potential benefits of
the Yoga-CaRe program could largely be attributed to
meeting the core objectives of conventional cardiac
rehabilitation programs: providing a structured pro-
gram of exercise and support to optimize physical and
psychosocial functioning, and improve health be-
haviors to slow disease progression. Given the low
intensity of exercise in Yoga-CaRe, improvements in
cardiac capacity and endorphin-mediated improve-
ments in mood are expected to be lower than aerobic
exercise. On the other hand, increasing evidence
suggests that breathing movements, meditation, and
stimulation of proprioceptors with stretching move-
ments of yoga may be associated with vascular and
mental health benefits through other pathways, such
as the stimulation of parasympathetic nervous sys-
tem (e.g., leading to improvements in heart rate
variability and vascular tone through greaterbaroreceptor sensitivity), reduction in stress and its
downstream vascular and endocrine effects (medi-
ated by hypothalamic-pituitary axis; e.g., lower
cortisol and reduced renin activity), and changes in
neurotransmitters (e.g., increase in serotonin and
decrease in dopamine) affecting mood and self-
efficacy (29–33). The Yoga-CaRe group showed a
greater improvement in self-rated health and reinte-
gration to normal life, suggesting that it may operate,
at least in part, through psychosocial pathways,
although a bidirectional relationship between psy-
chosocial and physical functioning in cardiac reha-
bilitation is previously reported (34). We did not find
a difference in medication adherence or tobacco
cessation between the treatment groups. Medication
adherence and tobacco cessation were relatively high
in both treatment groups, suggesting that lifestyle
advice provided to the control arm during educa-
tional sessions may have attenuated the observed
effects of the intervention.
STUDY LIMITATIONS. First, in common with previ-
ous trials of cardiac rehabilitation, our study was
underpowered (43% study power based on original
assumptions) for the composite outcome because of a
FIGURE 2 Hazard Ratios of Major Adverse Cardiovascular Event (Composite of Death, Nonfatal Myocardial Infarction, Nonfatal Stroke or Emergency
Cardiovascular Hospitalization) for Key Subgroups of Patients
Yoga-CaRe Enhanced Standard Care
0 0.5 1 1.5 2 2.5
Enhanced
Standard care
97/1,627 (6.0)
29/339 (8.6)
102/1,692 (6.0)
24/274 (8.8)
38/474 (8.0)
88/1,492 (5.9)
84/1,549 (5.4)
42/415 (10.1)
88/1,396 (6.3)
38/569 (6.7)
85/1,402 (6.1)
41/562 (7.3)
59/740 (8.0)
67/1,226 (5.5)
75/1,064 (7.1)
69/900 (7.7)
51/839 (6.1)
21/409 (5.1)
25/253 (9.9)
Yoga-CaRe
74/1,598 (4.6)
27/337 (8.0)
85/1,673 (5.1)
16/262 (6.1)
32/484 (6.6)
69/1,451 (4.8)
79/1,499 (5.3)
22/431 (5.1)
58/1,394 (4.2)
43/534 (8.1)
63/1,354 (4.7)
38/575 (6.6)
45/760 (5.9)
56/1,075 (4.8)
74/1,048 (7.1)
57/903 (6.3)
34/829 (4.1)
27/391 (6.9)
11/243 (4.5)
Subgroup
<65 Years
Age
≥65 Years
Sex
Male
Female
ST-segment elevation
No
Yes
Coronary Artery Disease
No
Yes
Diabetes
No
Yes
Hypertension
No
Yes
Revascularization
No
Yes
Physical Activity
Physically Inactive
Moderate to high active
Morphology
Single Vessel Disease
Double Vessel Disease
Triple Vessel Disease
Hazard Ratio
[95% CI]
0.77 (0.57-1.05)
0.9 (0.53-1.52)
0.84 (0.63-1.12)
0.67 (0.35-1.26)
0.77 (0.48-1.23)
0.82 (0.6-1.12)
0.98 (0.72-1.33)
0.49 (0.29-0.81)
0.65 (0.47-0.91)
1.2 (0.78-1.86)
0.76 (0.55-1.05)
0.9 (0.58-1.4)
0.75 (0.51-1.11)
0.85 (0.6-1.21)
1.03 (0.74-1.43)
0.84 (0.6-1.19)
0.66 (0.43-1.02)
1.36 (0.77-2.4)
0.44 (0.21-0.89)
p Value for
Interaction
0.63
0.53
0.83
0.02
0.03
0.54
0.65
0.32
0.05
0.3
Event rates were based on Kaplan-Meier estimates in time-to-event analysis over the study follow-up period (median 21.6 months). Hazard ratio for first major adverse
cardiovascular event was determined using a Cox proportional hazards model and the p values were calculated by using a log-rank test. CI ¼ confidence interval; Yoga-
CaRe ¼ yoga-based cardiac rehabilitation.
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1558lower than anticipated event rate (3). This may have
been because of improvements in cardiac care in In-
dia over the past decades. More than 90% of patients
were receiving #2 standard cardiovascular medica-
tions at hospital discharge in our trial. Our planned
follow-up of the trial participants for 2 more years
may provide evidence that is more conclusive. Sec-
ond, the trial population was relatively young andpredominantly male. This may reflect a combination
of local epidemiology (the average age of myocardial
infarction patients isw10 years younger in India) (35),
and the reluctance of recruiting clinicians and pa-
tients and their family members to enroll the elderly
and women in trials (3). Although this is unlikely to
affect the internal validity of the trial results, caution
should be exercised when generalizing the findings to
CENTRAL ILLUSTRATION Yoga-Based Cardiac Rehabilitation Versus Enhanced Standard Care in
Acute Myocardial Infarction
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Major adverse cardiovascular events (composite of all-cause mortality, myocardial infarction, stroke or emergency
cardiac hospitalization) over a median follow-up of 22 months: Enhanced standard care - 7.1% vs. Yoga-CaRe – 6.5%
Self-rated health at 12 weeks: Enhanced standard care – 75.7 vs. Yoga-CaRe – 77
3 Months Change Score
Regression coefficient, 1.5 (95% CI: 0.5-2.5, p = 0.002)
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Cumulative incidence of major adverse cardiovascular event (composite of death, nonfatal myocardial infarction, nonfatal stroke, or emergency cardio-
vascular hospitalization) in the study groups. Event rates were based on Kaplan-Meier estimates in time-to-event analysis over the study follow-up
period (median 21.6 months). Hazard ratio for first major adverse cardiovascular event was determined using a Cox proportional hazards model and the p
value used a log-rank test. Self-rated health was assessed by the visual analogue scale of the European Quality of Life (EQ-5D-5L) questionnaire at
baseline and at 12 weeks. Change score ¼ 12 weeks minus baseline. CI ¼ confidence interval; EQ-VAS ¼ European Quality of Life visual analogue scale;
Yoga-CaRe ¼ yoga-based cardiac rehabilitation.
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PERSPECTIVES
COMPETENCY IN PATIENT CARE: Yoga-based
cardiac rehabilitation is better than no rehabilitation
after acute myocardial infarction, improving self-rated
health and return to pre-infarct activities.
TRANSLATIONAL OUTLOOK: Longer-term
comparative studies are needed to evaluate the utility
of yoga-based cardiac rehabilitation in settings in
which conventional exercise-based programs are not
available or applicable.
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other countries in which yoga may be less acceptable
to patients. Once enrolled, we noted no difference in
adherence or clinical outcomes by age group and sex,
confirming our hypothesis that yoga-based cardiac
rehabilitation programs could contribute to improved
adherence among women and the elderly. Third,
conventional exercise-based cardiac rehabilitation
programs were lacking in most centers and it was not
feasible for us to introduce them as part of the trial
precluding advice on their relative benefits. Fourth,
in keeping with our scalability objectives, we evalu-
ated a low-intensity intervention (13 direct contact
sessions as opposed to 36 sessions in many U.S. pro-
grams) and made no effort to improve adherence to
the intervention, which may have underestimated
the potential benefits of Yoga-CaRe (as suggested by
the results of exploratory analyses). However, the
results of exploratory analysis should be interpreted
with caution, as it breaks the randomized group and
may be prone to selection bias. Finally, the inherent
limitation of the tools used for assessing quality of
life and return to pre-infarct activities, such as ceiling
effect and moderate responsiveness, in the short
term might have underestimated the effect of the
Yoga-CaRe program. However, the nonprotocol-
defined analyses of self-rated health involving cate-
gorical approaches following previously reported
methods provide a hypothetical framework for the
beneficial effects of Yoga-CaRe and support the clin-
ical and public health importance of our findings.
CLINICAL PRACTICE AND POLICY IMPLICATIONS.
Yoga-CaRe has the potential to address the unmet
need of disadvantaged groups worldwide. In low- and
middle-income countries, such as India, conventional
exercise-based cardiac rehabilitation programs are
lacking, as most hospitals cannot afford the infra-
structure and recruiting large multidisciplinary teams
is challenging (6,7). Hiring a single yoga teacher at
the cost of approximately USD $250 per month
(2018 prices), which is within the reach of most
medium-sized hospitals in India, could meet their
entire rehabilitation needs. It has been estimated
that approximately 1.5 million patients experience
myocardial infarction each year in India, which
highlights the considerable potential for saving
lives and reducing economic burden. In high-
income countries, such as the United States and
United Kingdom, the primary challenge is low
enrollment and adherence among certain subgroups(e.g., elderly, women, low-income). Distance to a
rehabilitation facility also can be a barrier to atten-
dance in many settings. Given the lack of direct
comparison with yoga-based cardiac rehabilitation
and a large body of existing evidence underpinning
its use, we recommend that, wherever available,
conventional exercise-based cardiac rehabilitation
should remain the treatment of choice, and Yoga-
CaRe should be reserved as a treatment option for
individual patients who choose not to enroll or
adhere to conventional cardiac rehabilitation pro-
grams (4,5). A randomized trial comparing conven-
tional and yoga-based cardiac rehabilitation may help
to inform practice in this regard.
CONCLUSIONS
The results of this trial show that a yoga-based car-
diac rehabilitation program can safely improve self-
rated health and return to pre-infarct activities after
acute myocardial infarction, although the trial lacked
statistical power to provide evidence of difference in
major adverse cardiovascular events.
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